Cargando…

Switch From Fetal to Adult SCN5A Isoform in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Unmasks the Cellular Phenotype of a Conduction Disease–Causing Mutation

BACKGROUND: Human induced pluripotent stem cell–derived cardiomyocytes (hiPSC‐CMs) can recapitulate features of ion channel mutations causing inherited rhythm disease. However, the lack of maturity of these cells is considered a significant limitation of the model. Prolonged culture of hiPSC‐CMs pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veerman, Christiaan C., Mengarelli, Isabella, Lodder, Elisabeth M., Kosmidis, Georgios, Bellin, Milena, Zhang, Miao, Dittmann, Sven, Guan, Kaomei, Wilde, Arthur A. M., Schulze‐Bahr, Eric, Greber, Boris, Bezzina, Connie R., Verkerk, Arie O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586268/ https://www.ncbi.nlm.nih.gov/pubmed/28739862 http://dx.doi.org/10.1161/JAHA.116.005135

Ejemplares similares

hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities
por: Veerman, Christiaan C., et al.
Publicado: (2016)

Maturation of hiPSC-derived cardiomyocytes promotes adult alternative splicing of SCN5A and reveals changes in sodium current associated with cardiac arrhythmia
por: Campostrini, Giulia, et al.
Publicado: (2022)

Patch-Clamp Recording from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Improving Action Potential Characteristics through Dynamic Clamp
por: Verkerk, Arie O., et al.
Publicado: (2017)

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
por: Hoekstra, Maaike, et al.
Publicado: (2012)

Genetic variation in GNB5 causes bradycardia by augmenting the cholinergic response via increased acetylcholine-activated potassium current (I(K,ACh))
por: Veerman, Christiaan C., et al.
Publicado: (2019)

Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Do not Improve with Carnitine Supplementation
por: Verkerk, Arie O., et al.
Publicado: (2021)

The W101C KCNJ5 Mutation Induces Slower Pacing by Constitutively Active GIRK Channels in hiPSC-Derived Cardiomyocytes
por: Kayser, Anne, et al.
Publicado: (2023)

Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual I(K1)
por: Meijer van Putten, Rosalie M. E., et al.
Publicado: (2015)

Disease Modifiers of Inherited SCN5A Channelopathy
por: Verkerk, Arie O., et al.
Publicado: (2018)

Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates
por: Knottnerus, Suzan J. G., et al.
Publicado: (2020)

Cardiac Subtype-Specific Modeling of K(v)1.5 Ion Channel Deficiency Using Human Pluripotent Stem Cells
por: Marczenke, Maike, et al.
Publicado: (2017)

A Heterozygous Deletion Mutation in the Cardiac Sodium Channel Gene SCN5A with Loss- and Gain-of-Function Characteristics Manifests as Isolated Conduction Disease, without Signs of Brugada or Long QT Syndrome
por: Zumhagen, Sven, et al.
Publicado: (2013)

Ultrarapid Delayed Rectifier K(+) Channelopathies in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Hilderink, Sarah, et al.
Publicado: (2020)

Absence of Functional Na(v)1.8 Channels in Non-diseased Atrial and Ventricular Cardiomyocytes
por: Casini, Simona, et al.
Publicado: (2020)

Disease Phenotypes and Mechanisms of iPSC-Derived Cardiomyocytes From Brugada Syndrome Patients With a Loss-of-Function SCN5A Mutation
por: Li, Wener, et al.
Publicado: (2020)

Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Aquaporin Channels in the Heart—Physiology and Pathophysiology
por: Verkerk, Arie O., et al.
Publicado: (2019)

Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
por: Giacomelli, E., et al.
Publicado: (2017)

Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome
por: Nasilli, Giovanna, et al.
Publicado: (2023)

Re-annotation of 191 developmental and epileptic encephalopathy-associated genes unmasks de novo variants in SCN1A
por: Steward, Charles A., et al.
Publicado: (2019)

Cryopreservation of human pluripotent stem cell-derived cardiomyocytes is not detrimental to their molecular and functional properties
por: van den Brink, Lettine, et al.
Publicado: (2020)

Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?
por: Sala, Luca, et al.
Publicado: (2016)

Induced pluripotent stem cells of patients with Tetralogy of Fallot reveal transcriptional alterations in cardiomyocyte differentiation
por: Grunert, Marcel, et al.
Publicado: (2020)

Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations
por: Casini, Simona, et al.
Publicado: (2017)

Variants in the SCN5A Promoter Associated With Various Arrhythmia Phenotypes
por: Yagihara, Nobue, et al.
Publicado: (2016)

Generation of self-assembling cardiac organoids using hiPSC-derived cardiomyocytes
por: Künzel, Karolina, et al.
Publicado: (2022)

Identification of an I(Na)-dependent and I(to)-mediated proarrhythmic mechanism in cardiomyocytes derived from pluripotent stem cells of a Brugada syndrome patient
por: Ma, Dongrui, et al.
Publicado: (2018)

Human iPS cell models of Jervell and Lange-Nielsen syndrome
por: Bellin, Milena, et al.
Publicado: (2015)

SCN5A Mutation Type and a Genetic Risk Score Associate Variably With Brugada Syndrome Phenotype in SCN5A Families
por: Wijeyeratne, Yanushi D., et al.
Publicado: (2020)

Enhanced impact of SCN5A mutation associated with long QT syndrome in fetal splice isoform
por: Wang, Tiannan, et al.
Publicado: (2011)

Genetic Basis of Ventricular Arrhythmias
por: Pazoki, Raha, et al.
Publicado: (2010)

Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection()()
por: Ussher, John R., et al.
Publicado: (2014)

Pilsicainide Administration Unmasks a Phenotype of Brugada Syndrome in a Patient with Overlap Syndrome due to the E1784K SCN5A Mutation
por: Hasebe, Hideyuki, et al.
Publicado: (2019)

Sodium Channel Remodeling in Subcellular Microdomains of Murine Failing Cardiomyocytes
por: Rivaud, Mathilde R., et al.
Publicado: (2017)

SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes
por: Wu, Cheng-I, et al.
Publicado: (2020)

Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes
por: Paci, Michelangelo, et al.
Publicado: (2018)

CRISPR‐Mediated Expression of the Fetal Scn5a Isoform in Adult Mice Causes Conduction Defects and Arrhythmias
por: Pang, Paul D., et al.
Publicado: (2018)

“Pill-in-the-Pocket” Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient With a Common SCN5A R1193Q Polymorphism
por: Li, Linling, et al.
Publicado: (2019)

Human pluripotent stem cell-derived cardiomyocytes: Genome-wide expression profiling of long-term in vitro maturation in comparison to human heart tissue
por: Piccini, Ilaria, et al.
Publicado: (2015)

IP3R-Mediated Compensatory Mechanism for Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes With Cardiac Ryanodine Receptor Deficiency
por: Luo, Xiaojing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jvkmm8nu2noq9bm43lrn9qd3mb